Rezolute (RZLT) Change in Acquisitions & Divestments (2023 - 2026)
Rezolute (RZLT) posted Change in Acquisitions & Divestments of $49.3 million for Q1 2026, down 0.9% sequentially from $49.7 million in Q4 2025, and up 96.45% YoY from $25.1 million in Q1 2025.
Analysis
Rezolute (RZLT) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
Rezolute has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $49.3 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 96.45% year-over-year to $49.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147.2 million (up 27.81% YoY) and the FY2025 annual result came in at $113.6 million, down 1.3% from the prior year.
- Change in Acquisitions & Divestments eased to $49.3 million in Q1 2026 per RZLT's latest filing, from $49.7 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $49.7 million in Q4 2025 and troughed at $18.6 million in Q3 2023.
- A 4-year average of $31.6 million and a median of $27.8 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments decreased 14.39% in 2025, then surged 96.45% in 2026.
- Over 4 years, Change in Acquisitions & Divestments stood at $41.9 million in 2023, then dropped by 11.99% to $36.9 million in 2024, then surged by 34.69% to $49.7 million in 2025, then retreated by 0.9% to $49.3 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $49.3 million, $49.7 million, and $20.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 49.30 Mn |
| Dec 31, 2025 | 49.70 Mn |
| Sep 30, 2025 | 20.40 Mn |
| Jun 30, 2025 | 27.80 Mn |
| Mar 31, 2025 | 25.07 Mn |
| Dec 31, 2024 | 36.90 Mn |
| Sep 30, 2024 | 23.83 Mn |
| Jun 30, 2024 | 29.33 Mn |
| Mar 31, 2024 | 25.24 Mn |
| Dec 31, 2023 | 41.93 Mn |
| Sep 30, 2023 | 18.60 Mn |